Teresa V. Halbsguth

Frankfurt Am Main, HE 60590, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

From information to action: how medical reports can support general practitioners in long-term cancer care-a qualitative exploratory study.

From information to action: how medical reports can support general practitioners in long-term cancer care-a qualitative exploratory study.

Journal: Journal of cancer survivorship : research and practice
Published: April 15, 2026

Feasibility of Integrating a Standardized Psychosocial Follow-Up After Childhood Cancer-An Interim Analysis of the LE-Na Study.

Feasibility of Integrating a Standardized Psychosocial Follow-Up After Childhood Cancer-An Interim Analysis of the LE-Na Study.

Journal: Cancer medicine
Published: October 31, 2025

Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL Trial.

Gonadal Function and Fertility after Hodgkin Lymphoma Treatment with Nivolumab-AVD in the Phase II GHSG NIVAHL Trial.

Journal: Blood
Published: September 25, 2025

Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial.

Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial.

Journal: Blood
Published: September 25, 2025

Multifocal Rosai Dorfman disease and simultaneous endometrioid ovarian cancer: a case report.

Multifocal Rosai Dorfman disease and simultaneous endometrioid ovarian cancer: a case report.

Journal: Journal of medical case reports
Published: September 11, 2025

Long-term surveillance recommendations for young adult cancer survivors.

Long-term surveillance recommendations for young adult cancer survivors.

Journal: Cancer treatment reviews
Published: April 22, 2025

Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencing.

Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencing.

Journal: Leukemia
Published: February 08, 2025

Evaluation and implementation of multidisciplinary, standardized, guideline-based long-term follow-up care for adult survivors of childhood cancer in Germany: protocol of a prospective, multi-center, nationwide study (LE-Na).

Evaluation and implementation of multidisciplinary, standardized, guideline-based long-term follow-up care for adult survivors of childhood cancer in Germany: protocol of a prospective, multi-center, nationwide study (LE-Na).

Journal: BMC cancer
Published: October 24, 2024

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.

Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 12, 2022

Corrigendum to "Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial": Annals of Oncology 2012; 23: 1818-1825.

Corrigendum to "Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial": Annals of Oncology 2012; 23: 1818-1825.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 20, 2020

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

Journal: The Lancet. Oncology
Published: May 28, 2020

Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.

Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.

Journal: JAMA oncology
Published: May 01, 2020
Showing 1-12 of 22

Last Updated: 09/26/2026